Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review


     Quick Explanation



    Ten rules that mainly target bias control in neuroimaging meta-analysis
    This paper is a best-practice + reporting checklist focused on coordinate-based neuroimaging meta-analysis: define the question/criteria up front, keep search coverage and reference space consistent, handle repeated contrasts, double-check extracted coordinates, correct for multiple comparisons, run diagnostics, and report enough detail to reproduce the pipeline and inclusion decisions.



     Long Explanation



    Paper review (methodology checklist): Ten simple rules for neuroimaging meta-analysis
    Core thesis: reliable neuroimaging meta-analytic conclusions require explicit control of (i) what is pooled, (ii) whether inference spaces/coverage are comparable, (iii) dependency created by multiple contrasts from the same subjects, (iv) extraction errors, (v) multiplicity and error-rate reporting, and (vi) diagnostics + traceable reporting.
    Paper metadata snapshot
    • Publication: 2017 (accepted Nov 2017; published 24 Nov 2017)
    • Format: methodological guidelines + checklist
    • Primary target: coordinate-based CBMA; many rules extend to image-based
    VISUAL 1 β€” β€œScore-bar” view of the paper-review rubric you provided
    VISUAL 2 β€” Ten rules as a β€œquality-control pipeline”
    Note: the numeric weights in this figure are not from the paper; they are a visualization-only heuristic to help you see the intended emphasis across rules. The underlying rule content is from the paper’s ten-rule structure.
    VISUAL 3 β€” Checklist β€œcoverage map” (rule-to-item index)
    This heatmap is again a visual aid, not an encoded fact from the paper. The conceptual targets (question definition, inclusion criteria, space consistency, contrast dependence, QC, preregistration/planning, multiplicity/error control, diagnostics, transparent reporting) come directly from the paper’s ten-rule text.
    What the paper gets right (skeptical but favorable)
    • It attacks the core reproducibility failure modes specific to coordinate-based CBMA: inconsistent inference spaces (ROI/SVC vs whole-brain), reference-space mismatch (MNI vs Talairach), dependence from multiple contrasts, and transcription/sign errors in extracted coordinates.
    • It clarifies an interpretation trap: in coordinate-based meta-analysis, significance reflects spatial convergence in a null space, not the magnitude/direction of activation/deactivation (contrast sign information is lost in typical CBMA).
    • It incentivizes preregistration and β€œanalysis-before-seeing” discipline to combat multiple testing degrees of freedom and p-hacking-like behavior in meta-analytic pipelines (including stopping rules like β€œrepeat until significant”).
    • It demands diagnostics (contribution analysis, funnel plots, heterogeneity/meta-regression where appropriate) so readers can evaluate whether clusters are robust or driven by small/odd subgroups.
    Critical blind spots & limitations (what this checklist does *not* fully solve)
    • No guarantee of empirical accuracy: the paper provides guidelines, but it does not itself demonstrate (within the paper) that adherence improves replication rates across many topicsβ€”so the checklist is strongest as a process quality control framework, not as a proven causal lever.
    • Publication bias is conceptually different in CBMA: coordinate-based methods test convergence and may be insensitive to some forms of non-significant-result suppression; thus β€œusual” bias checks may not work as directly as in effect-size meta-analysis.
    • β€œSame search coverage” can be fuzzy in practice: the checklist discusses excluding explicit ROI/SVC and assessing hidden/partial coverage via acquisition parameters, but real-world reporting is incomplete in many papersβ€”so the meta-analyst may face uncertainty and have to contact authors or make judgment calls.
    • Degrees of freedom remain across β€œallowed” branches: even with preregistration, inclusion of different contrast handling, thresholds, null-space adjustments (e.g., ROI masks), and sensitivity analyses can still create flexibility; the paper warns about this generally by recommending planning and transparency, but it can’t eliminate it.
    VISUAL 4 β€” β€œRule 4” risk: what changes if coverage/reference space differs?
    The plot illustrates the paper’s logic: coordinate-based CBMA often tests convergence against a null assuming whole-brain uniform opportunity; including ROI/SVC or mismatched search coverage/reference space can inflate apparent significance by violating the null model.
    Rule-by-rule critique (skimmable)
    Rule Main purpose Most likely failure mode if ignored
    1Specify research question, paradigms/contrasts, inclusion/exclusion criteriaPooling mismatched cognitive processes β†’ weak/heterogeneous convergence interpretation
    2Consider power: enough experiments but also balance heterogeneity vs specificitySmall-N meta-analysis driven by few studies β†’ poor generalization
    3Collect/organize data with tracking; extract required metadata (coords, N, space, inference)Ineligible studies included; missing space/threshold metadata; extraction errors
    4Same search coverage + align reference space (MNI/Talairach); exclude/adapt ROI/SVC/partial coverageNull-space violation β†’ inflated false convergence
    5Adjust for multiple contrasts (dependence within subject group)Over-counting dependent contrasts β†’ invalid uncertainty
    6Double-check extracted coordinates/spaces; QC diagnostics like map/peak plausibilitySign errors, wrong space labels, out-of-mask coordinates silently contaminating results
    7Plan analyses beforehand; preregister protocol (mark deviations)Degrees-of-freedom exploitation β†’ distorted p-values & selective reporting of analyses
    8Balance sensitivity and false positives with multiple-comparison control & thresholdsChance findings dominate future literature β†’ unreliable follow-ups
    9Show diagnostics: contributions, funnel plots, heterogeneity/robustnessClusters driven by one subgroup/small studies go undetected
    10Be transparent: report flow chart, experiment-level table, included contrasts, QC/adjustmentsOthers cannot reconstruct inclusion decisions or verify coordinate extraction
    Each row is a compact restatement of the paper’s ten-rule intent.
    What would change my mind? (falsification-oriented reflection)
    • If future empirical studies show that strict adherence to these rules does not improve reproducibility/traceability (e.g., replication rates and external validation fail to improve), then the checklist would be less impactful as a process prescription.
    • If coordinate-based convergence meta-analysis (under well-specified null spaces) is shown to permit more direct inference about effect magnitude/direction than the paper claims, then the interpretational caution would require revision.


    Feedback:    

    Updated: March 29, 2026

     BGPT Paper Review



    Study Novelty

    80%

    Novelty is high because it converts recurring CBMA methodological failure modes into a concrete, prescriptive checklist and transparency requirements for meta-analytic workflows, rather than a purely conceptual discussion.



    Scientific Quality

    90%

    Scientific quality is strong as a methodological synthesis: it targets known neuroimaging inference pitfalls (space/coverage mismatch, ROI/SVC inclusion, repeated contrasts, multiple-comparison error rates, QC/extraction mistakes) and explicitly warns about interpretational limits of coordinate-based convergence.



    Study Generality

    90%

    Although focused on coordinate-based CBMA, most rules generalize to many neuroimaging meta-analyses because they address universal issues: eligibility specification, extraction/QC, inference-space comparability, error-rate control, diagnostics, and transparent reporting.



    Study Usefulness

    90%

    Extremely useful as a compliance checklist: it is actionable for authors (methods/reporting) and reviewers (auditability) and improves interpretability by separating convergence evidence from activation magnitude claims.



    Study Reproducibility

    90%

    High reproducibility potential because it requires traceability (search strategy tracking; experiment/contrast lists; space conversions/handling; QC and adjustments reporting) and recommends preregistering analysis plans.



    Explanatory Depth

    80%

    The paper’s explanations are mechanistically grounded in statistical assumptions (null-space validity, dependence across contrasts, how convergence testing differs from activation effect interpretation) but remain mainly methodological rather than biological.


    🎁 Authors: Collect 500 Free Science Tokens (β‰ˆ $50.0 USD)

    Claim My Author Tokens

    Use for 125 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $50.0 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    Not applicable: this is a methodological review of neuroimaging meta-analysis rules, not a data-extraction or biological compute task requiring code from provided datasets.



     Hypothesis Graveyard



    The null-space mismatch between whole-brain vs ROI/SVC is a minor technicality that does not meaningfully inflate convergence significance; instead, it is likely to be negligible even under common inclusion errors. (Rejected by the paper’s explicit argument that ROI/SVC inclusion violates convergence null assumptions.)


    Interpretations of coordinate-based meta-analysis as β€œincreased activation” are mostly correct when meta-analyses include only significant peaks; the sign/magnitude issue is overemphasized. (Rejected by the paper’s conceptual statement that coordinate-based CBMA lacks activation sign/magnitude information.)

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT